Sonoma Pharma (SNOA): מחיר למכירות

לוגו תאגידי של חברת Sonoma Pharma (SNOA)

P/S volatility on the GURU.Markets chart demonstrates the impact of implementing robotic AI filling lines for sterile solutions for Sonoma Pharmaceuticals (SNOA). This price action is supported by Microcyn patents, which create a high barrier to entry, and strict FDA oversight. Business stability relies on US-based production capacities for medical and veterinary drugs, while the value of 0.20 represents the current figure for this metric.

SNOA (Sonoma Pharmaceuticals) היסטוריית יחס מחיר להכנסות מ-04.07.2022 עד 17.11.2026

פילוחים אנליטיים של חברת sonomapharma.com (SNOA)

- מחיר ותחזית קונצנזוס למחירים:
אנליטיקה מסכמת של החברה:Sonoma Pharmaceuticals, SNOA
מוצר מקורי של Sonoma Pharmaceuticals

The patent-protected dermatological product line of Sonoma Pharmaceuticals (SNOA) is valued using the price-to-sales ratio. By analyzing the current price-to-sales value, an investor determines the cost of each dollar of revenue, allowing for a comparison of market capitalization against actual cash flow from drug sales, which confirms the fundamental stability of the business amidst regulatory barriers.